Search Orphan Drug Designations and Approvals
-
Generic Name: | axicabtagene ciloleucel |
---|---|
Date Designated: | 03/24/2020 |
Orphan Designation: | Treatment of nodal marginal zone lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Kite Pharma, Inc. 2400 Broadway Santa Monica, California 90404 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-